Please provide your email address to receive an email when new articles are posted on . Young children with type 1 diabetes had similar glycemic outcomes using fast-acting insulin aspart vs. standard ...

The rising global diabetes burden, particularly Type 1 and Type 2, is a key driver for the rapid acting insulin market. As per the International Diabetes Federation, more than 530 million adults lived ...

Scientists in Melbourne have designed a new type of oral capsule that could mean pain-free delivery of insulin and other protein drugs. Co-lead researcher Professor Charlotte Conn, a biophysical ...

Please provide your email address to receive an email when new articles are posted on . Fast-acting insulin aspart provides similar time in range as insulin aspart for adults with type 1 diabetes ...

Due to a lack of suitable studies, it remains unclear whether children and adolescents with type 1 diabetes benefit more or less from long-term treatment with rapid-acting insulin analogues than with ...

(RTTNews) - The U.S. Food and Drug Administration announced that Sanofi-Aventis U.S. LLC's Merilog (insulin-aspart-szjj) becomes the first rapid-acting insulin biosimilar product to get its approval ...

Use of Regular Human Insulin could save U.S. patients with type 2 diabetes and healthcare systems thousands of dollars per patient annually BRIDGEWATER, N.J., Aug. 15, 2019 (GLOBE NEWSWIRE) -- ...

Humalog is given as an injection, and there are two types of the drug: Some forms of Humalog and Humalog Mix are available as generics or biosimilars. To learn more, see “Generic or biosimilar ...

For millions of people with diabetes, insulin is essential medicine. But for some ocean-dwelling predators, insulin is a weapon. With a burst of venom, a fish-hunting cone snail can drop the blood ...

Treatment with the diabetes and weight loss drug semaglutide may allow people newly diagnosed with Type 1 diabetes to dramatically cut back or even completely stop insulin injections, a very small ...